371 related articles for article (PubMed ID: 16688207)
1. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
Rivière C; Danos O; Douar AM
Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
[TBL] [Abstract][Full Text] [Related]
2. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain.
Wang C; Wang CM; Clark KR; Sferra TJ
Gene Ther; 2003 Aug; 10(17):1528-34. PubMed ID: 12900769
[TBL] [Abstract][Full Text] [Related]
3. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.
Chao H; Liu Y; Rabinowitz J; Li C; Samulski RJ; Walsh CE
Mol Ther; 2000 Dec; 2(6):619-23. PubMed ID: 11124063
[TBL] [Abstract][Full Text] [Related]
4. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.
Bouchard S; MacKenzie TC; Radu AP; Hayashi S; Peranteau WH; Chirmule N; Flake AW
J Gene Med; 2003 Nov; 5(11):941-50. PubMed ID: 14601131
[TBL] [Abstract][Full Text] [Related]
5. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.
Blankinship MJ; Gregorevic P; Allen JM; Harper SQ; Harper H; Halbert CL; Miller AD; Chamberlain JS
Mol Ther; 2004 Oct; 10(4):671-8. PubMed ID: 15451451
[TBL] [Abstract][Full Text] [Related]
6. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
Le HT; Yu QC; Wilson JM; Croyle MA
J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer into skeletal muscle using novel AAV serotypes.
Louboutin JP; Wang L; Wilson JM
J Gene Med; 2005 Apr; 7(4):442-51. PubMed ID: 15517544
[TBL] [Abstract][Full Text] [Related]
8. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer.
Wang L; Cao O; Swalm B; Dobrzynski E; Mingozzi F; Herzog RW
Gene Ther; 2005 Oct; 12(19):1453-64. PubMed ID: 15889137
[TBL] [Abstract][Full Text] [Related]
9. Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors.
Kok MR; Voutetakis A; Yamano S; Wang J; Cotrim A; Katano H; Bossis I; Chiorini JA; Tran SD; Tak PP; Baum BJ
J Gene Med; 2005 Apr; 7(4):432-41. PubMed ID: 15515118
[TBL] [Abstract][Full Text] [Related]
10. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
[TBL] [Abstract][Full Text] [Related]
11. Regulation of gene expression in vivo following transduction by two separate rAAV vectors.
Rendahl KG; Leff SE; Otten GR; Spratt SK; Bohl D; Van Roey M; Donahue BA; Cohen LK; Mandel RJ; Danos O; Snyder RO
Nat Biotechnol; 1998 Aug; 16(8):757-61. PubMed ID: 9702775
[TBL] [Abstract][Full Text] [Related]
12. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
13. Enhancing rAAV vector expression in the lung.
Virella-Lowell I; Zusman B; Foust K; Loiler S; Conlon T; Song S; Chesnut KA; Ferkol T; Flotte TR
J Gene Med; 2005 Jul; 7(7):842-50. PubMed ID: 15838934
[TBL] [Abstract][Full Text] [Related]
14. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
16. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.
Peden CS; Burger C; Muzyczka N; Mandel RJ
J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728
[TBL] [Abstract][Full Text] [Related]
17. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter.
Sun B; Zhang H; Franco LM; Brown T; Bird A; Schneider A; Koeberl DD
Mol Ther; 2005 Jun; 11(6):889-98. PubMed ID: 15922959
[TBL] [Abstract][Full Text] [Related]
18. Femoral intra-arterial injection: a tool to deliver and assess recombinant AAV constructs in rodents whole hind limb.
Gonin P; Arandel L; Van Wittenberghe L; Marais T; Perez N; Danos O
J Gene Med; 2005 Jun; 7(6):782-91. PubMed ID: 15693034
[TBL] [Abstract][Full Text] [Related]
19. Persistent expression of canine factor IX in hemophilia B canines.
Chao H; Samulski R; Bellinger D; Monahan P; Nichols T; Walsh C
Gene Ther; 1999 Oct; 6(10):1695-704. PubMed ID: 10516718
[TBL] [Abstract][Full Text] [Related]
20. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
